Highlights
A collection of news and information related to Vivus Inc. published by this site and its partners.
Displaying items 1-8 of 8
» View ktuu.com items only
-
Obesity drugs lumber toward marketplace
Booster ShotsAbout this time last year, we were reporting on the failure of several investigational weight-loss medications. They included Sanofi-Aventis' rimonabant as well as two other drugs that aimed to work by blocking cannabinoid receptors in the brain. However,... -
Nuevo rival para el Viagra
Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer...Tags: Drugs and Medicines, Lilly Eli & Co, Health, Viagra (drug), GlaxoSmithKline PLC
-
Diet drug Qnexa: Don't get too carried away by new study
The diet drug Qnexa helps obese people with weight-related medical conditions to lose more weight than those who take a dummy pill and could allow some to scale back on medications for diabetes, high blood pressure or cholesterol, according to a new study...Tags: Diabetes, Pharmaceuticals, Contrave (drug), Health, High Blood Pressure
-
FDA shoots down another weight loss drug [Updated]
![The FDA has <a title="Arena Pharmaceuticals' press release" href="http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=521977" target="_blank">told the makers</a> of the proposed weight-loss drug Lorcaserin that it will not at this time approve the marketing of the medication, citing concerns about its marginal effectiveness and about cancers that occurred at higher-than-usual rates in animal studies. [<b>Updated Oct. 25, 10:35 a.m.</b> An earlier version of this article said cancers occurred at higher-than-usual-rates during clinical trials.]](http://www.latimes.com/media/thumbnails/story/2010-10/57020075-24134236-187105.JPG "The FDA has <a title=\"Arena Pharmaceuticals' press release\" href=\"http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=521977\" target=\"_blank\">told the makers</a> of the proposed weight-loss drug Lorcaserin that it will not at this time approve the marketing of the medication, citing concerns about its marginal effectiveness and about cancers that occurred at higher-than-usual rates in animal studies. [<b>Updated Oct. 25, 10:35 a.m.</b> An earlier version of this article said cancers occurred at higher-than-usual-rates during clinical trials.]")
The FDA has told the makers of the proposed weight-loss drug Lorcaserin that it will not at this time approve the marketing of the medication, citing concerns about its marginal effectiveness and about cancers that occurred at higher-than-usual rates...Tags: Internists, Diabetes, Pharmaceuticals, Trials, Health
-
Diet drugs face tough test
Tribune NewspapersThere has never been a magic prescription to help millions of obese Americans lose weight. Whether one is any closer to reality is now under scrutiny. A Food and Drug Administration advisory panel will decide Wednesday whether the diet drug Meridia...Tags: Internists, Diabetes, Pharmaceuticals, High Blood Pressure, San Diego (San Diego, California)
-
Teaming up to save your skin
Daily PressProducts by two Hampton Roads organizations are on the cutting edge of wound care. The nonprofit LifeNet Health in Virginia Beach offers TheraSkin, a graft made of real skin that stimulates your body to heal itself. Soluble Systems of Newport News...Tags: Hampton Roads, Internists, Diabetes, Newport News (Newport News, Virginia), Health
-
The scorecard on obesity drugs: 0 for 3
Los Angeles Times Staff WriterThis is not shaping up to be a good year for people seeking medical help for weight loss. A Food and Drug Administration advisory committee on Thursday voted against recommending approval of the drug lorcaserin. This is the third negative vote on...Tags: Internists, Pharmaceuticals, Health, Obesity, Weight Loss
-
Orgasm Inc. -- The Hunt for the Female Viagra
KTLA NewsLOS ANGELES -- It's a condition called 'Female Sexual Dysfunction," or 'FSD,' supposedly afflicting women who are dissatisfied with their sex lives. It's been widely reported to affect 43 percent of all women -- but it is real? Documentary filmmaker...Tags: Cinema Industry, Pharmaceuticals, Health, Viagra (drug), KTLA
Oct 28, 2009
| Los Angeles Times
Apr 30, 2012
|Story| South Florida Sun-Sentinel
Apr 11, 2011
|Story| Los Angeles Times
Oct 25, 2010
|Story| Los Angeles Times
Sep 15, 2010
|Story| Chicago Tribune
Nov 17, 2010
|Story| Daily Press
Sep 17, 2010
|Story| Los Angeles Times
May 5, 2010
|Story| KTLA-LTV
Original site for Vivus Inc. topic gallery.